The short answer: peptides are short chains of amino acids that act on cell-surface receptors and signalling pathways, whereas SARMs (selective androgen receptor modulators) are small, non-peptide molecules designed to bind the androgen receptor selectively. In other words, the two differ in chemical structure, molecular size and mechanism. This article compares the two compound classes at a structural and mechanistic level only. All materials supplied by Reta Research are for research use only, not for human or veterinary use.
What peptides are
Peptides are biological molecules built from amino acids joined by peptide bonds. They sit between individual amino acids and larger proteins on the size scale, typically ranging from a few residues to several dozen. Because they are assembled from the same building blocks as the body's own signalling molecules, many research peptides are close analogues of endogenous hormones, growth factors or gut-derived signals.
Structurally, a peptide's sequence of amino acids determines how it folds and which receptors it can engage. Most peptides act at the cell surface: they bind to specific receptors — often G-protein-coupled receptors — and trigger intracellular signalling cascades such as cyclic AMP or kinase pathways. This receptor-and-signalling mode of action is the defining feature of the class. Peptides are generally water-soluble, are supplied to laboratories in lyophilised (freeze-dried) form for stability, and are reconstituted before use.
Because peptides are relatively large and are readily broken down by digestive enzymes, they are not typically studied via oral routes in research settings; parenteral handling is the norm in preclinical work. Their diversity is considerable, spanning metabolic signalling peptides, growth-factor analogues and many other families.
What SARMs are
SARMs — selective androgen receptor modulators — are a class of small synthetic molecules that interact with the androgen receptor. Unlike peptides, they are not made from amino acids; they are small-molecule organic compounds with a defined chemical scaffold. The word "selective" refers to their design intent: to engage the androgen receptor in a tissue-selective manner rather than acting broadly like classical steroidal androgens.
Mechanistically, a SARM binds to the androgen receptor, which is an intracellular (nuclear) receptor. Once bound, the receptor complex can modulate gene transcription. This is a fundamentally different pathway from the cell-surface receptor signalling that characterises many peptides: SARMs act at a nuclear receptor and influence transcriptional activity, whereas peptides more commonly initiate signalling from the cell membrane.
SARMs are described here purely to characterise the compound class in a research context. Their small-molecule structure means they are often studied via different routes and formulations from peptides. Nothing here should be read as encouragement to use SARMs; Reta Research does not supply them, and this section is included only to explain how the two classes differ.
Key differences
The clearest way to separate the two classes is to compare them attribute by attribute. The table below summarises the structural and mechanistic distinctions relevant to research characterisation.
| Attribute | Peptides | SARMs |
|---|---|---|
| Chemical structure | Chains of amino acids linked by peptide bonds | Small non-peptide organic molecules |
| Target / mechanism | Bind cell-surface receptors and trigger signalling cascades | Bind the intracellular androgen receptor and modulate gene transcription |
| Molecular size | Larger; several to dozens of amino acid residues | Smaller; low-molecular-weight compounds |
| Handling in research | Usually supplied lyophilised and reconstituted; handled parenterally in preclinical work | Small molecules; different formulation and handling from peptides |
| Regulatory framing | Supplied strictly for research use only | Supplied strictly for research use only where available; not offered by Reta Research |
In summary, the divide is structural first (amino-acid chain versus small molecule), which in turn drives the mechanistic difference (cell-surface signalling versus nuclear-receptor modulation) and the practical difference in how each is handled in the laboratory.
Where Reta Research fits
Reta Research specialises in research peptides. Our catalogue is built around peptide chemistry, and every item is intended for laboratory research use only. We do not position ourselves as a SARM supplier; the comparison above is provided so researchers can understand where the two classes sit relative to one another.
If your work involves peptide signalling, you can browse the full range in our Peptides collection. Metabolic and incretin-signalling researchers may find our GLP-1s collection particularly relevant, while the complete catalogue is available under All Products. For a broader orientation to the class, see our complete guide to research peptides.
Frequently asked questions
How do peptides and SARMs differ structurally?
Peptides are chains of amino acids joined by peptide bonds and typically act on cell-surface receptors, whereas SARMs are small non-peptide molecules that bind the intracellular androgen receptor. The two classes differ in building blocks, molecular size and mechanism of action. This is a structural comparison only and is not a safety or therapeutic assessment.
Are SARMs peptides?
No. Despite sometimes being discussed alongside one another, SARMs are not peptides. Peptides are amino-acid-based molecules, while SARMs are small synthetic organic compounds with a different chemical scaffold and a different receptor target.
Which class do researchers use for what?
In general terms, peptides are studied in the context of receptor signalling across many biological systems — metabolic, growth-factor and hormone-analogue pathways among them — while SARMs are studied specifically in relation to androgen-receptor biology. The appropriate class depends entirely on the receptor system a given study is designed to probe.
Does Reta Research sell SARMs?
No. Reta Research specialises in research peptides and does not sell SARMs. The information here is educational, intended to explain how the two compound classes differ at a structural and mechanistic level.
Ready to source HPLC-tested material with per-batch documentation? Explore our Peptides collection to find the compound suited to your research question.
Related reading
- Research Peptides UK 2026: The Complete Guide
- What Is Retatrutide? A Research Overview of the Triple Agonist
- How Research Peptides Are Tested: HPLC, Mass Spectrometry & COAs
All products are supplied for research use only and are not for human or veterinary use. The information above compares compound classes at a structural and mechanistic level only and is not medical, dosing, safety or therapeutic guidance.